{"result":[{"lastName":"Gotlib","clinicalFocus":[{"focus":"Hematology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4046&type=small&showNoImage","displayName":"Jason Gotlib","firstName":"Jason","href":"http://med.stanford.edu/profiles/cancer/researcher/Jason_Gotlib","researchInterest":"My research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:\r\n--Myelodysplastic syndromes (MDS)\r\n--Chronic myelogenous leukemia (CML)\r\n--Acute myelogenous leukemia (AML)\r\n--Myeloproliferative disorders (MPDs) including:\r\n    Hypereosinophilic syndrome\r\n    Systemic mastocytosis\r\n    BCR-ABL-negative MPDs"},{"lastName":"Medeiros","clinicalFocus":[{"focus":"Hematology"},{"focus":"Acute leukemia"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7743&type=small&showNoImage","displayName":"Bruno Medeiros","firstName":"Bruno","href":"http://med.stanford.edu/profiles/cancer/researcher/Bruno_Medeiros","researchInterest":"My clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia."},{"lastName":"Klein","clinicalFocus":[],"appointments":[{"appointment":"Sr Research Engineer (PI Waiver),Genetics"}],"primaryAppointment":"Sr Research Engineer (PI Waiver),Genetics","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6129&type=small&showNoImage","displayName":"Teri Klein","firstName":"Teri","href":"http://med.stanford.edu/profiles/cancer/researcher/Teri_Klein","researchInterest":"Co-founder, Pacific Symposium on Biocomputing\r\nNIEHS, Site Visit Reviewer\r\nNIH, Study Section Reviewer"},{"lastName":"Carrillo","clinicalFocus":[],"appointments":[{"appointment":"Assistant Director, PharmGKB,Genetics"},{"appointment":"Engr Res Assoc,Genetics"}],"primaryAppointment":"Assistant Director, PharmGKB,Genetics","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=27085&type=small&showNoImage","displayName":"Michelle Whirl Carrillo","firstName":"Michelle","href":"http://cancer.stanford.edu/profiles/Michelle_Carrillo","researchInterest":""},{"lastName":"George","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3926&type=small&showNoImage","displayName":"Tracy I. George","firstName":"Tracy","href":"http://med.stanford.edu/profiles/cancer/researcher/Tracy_George","researchInterest":"My interest in translational hematopathology includes systemic mastocytosis and other myeloproliferative neoplasms, laboratory hematology, post-transplant and immunodeficiency-related lymphoproliferative disorders, and reactive lymphadenopathies. I am the pathologist on two clinical trials in treating aggressive types of systemic mastocytosis with an alternative small molecule inhibitor. I chair CAP's Hematology & Clinical Microscopy Resource Committee."},{"lastName":"Arber","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Hematopathology"},{"focus":"Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3925&type=small&showNoImage","displayName":"Daniel A. Arber, M.D.","firstName":"Daniel","href":"http://med.stanford.edu/profiles/cancer/researcher/Daniel_Arber","researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors."},{"lastName":"Nakasone","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Medicine"}],"primaryAppointment":"Postdoctoral Research fellow, Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=36670&type=small&showNoImage","displayName":"Hideki Nakasone","firstName":"Hideki","href":"http://med.stanford.edu/profiles/postdocs/researcher/Hideki_Nakasone","researchInterest":""},{"lastName":"Laport","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4546&type=small&showNoImage","displayName":"Ginna G. Laport","firstName":"Ginna","href":"http://med.stanford.edu/profiles/cancer/researcher/Ginna_Laport","researchInterest":"haploidentical transplantation, follicular lymphoma, adoptive immunotherapy,supportive care"},{"lastName":"Skinner","clinicalFocus":[{"focus":"Cancer > urologic oncology"},{"focus":"Bladder Cancer"},{"focus":"Continent urinary reservoir"},{"focus":"urinary tract reconstruction"},{"focus":"testis cancer"},{"focus":"Kidney Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Professor - Med Center Line,Urology"}],"primaryAppointment":"Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=32891&type=small&showNoImage","displayName":"Eila C. Skinner","firstName":"Eila","href":"http://med.stanford.edu/profiles/cancer/researcher/Eila_Skinner","researchInterest":"My research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer.  This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management.  I have also focused on optimizing the  use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life."},{"lastName":"Johnston","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Graft-Versus-Host Disease"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4572&type=small&showNoImage","displayName":"Laura Johnston","firstName":"Laura","href":"http://med.stanford.edu/profiles/cancer/researcher/Laura_Johnston","researchInterest":"Clinical research in allogeneic and autologous hematopoietic cell transplantation (HCT), more specifically, allogeneic transplantation and graft versus host disease. Exploring methods of improving prevention and treatment of GVHD as well as the long term follow-up and/or quality of life of affected patients."},{"lastName":"Alizadeh","clinicalFocus":[{"focus":"Oncology"},{"focus":"Lymphoma"},{"focus":"B-Cell Chronic Lymphocytic Leukemia"},{"focus":"Waldenstrom Macroglobulinemia"},{"focus":"Burkitt Lymphoma"},{"focus":"Follicular Lymphoma"},{"focus":"Diffuse Large-Cell Lymphomas"},{"focus":"Leukemia, Hairy Cell"},{"focus":"Lymphoma, B-Cell, Marginal Zone"},{"focus":"Hodgkin Disease"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=9558&type=small&showNoImage","displayName":"Ash A. Alizadeh, MD/PhD","firstName":"Arash","href":"http://med.stanford.edu/profiles/cancer/researcher/Arash_Alizadeh","researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma."},{"lastName":"Patel","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Medical fellow, Medicine"}],"primaryAppointment":"Postdoctoral Medical fellow, Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=20863&type=small&showNoImage","displayName":"Manali Patel","firstName":"Manali","href":"http://med.stanford.edu/profiles/postdocs/researcher/Manali_Patel","researchInterest":""},{"lastName":"Duque Afonso","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Pathology"}],"primaryAppointment":"Postdoctoral Research fellow, Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=29334&type=small&showNoImage","displayName":"Atilio Jesus Duque-Afonso","firstName":"Atilio","href":"http://med.stanford.edu/profiles/postdocs/researcher/Atilio_Duque Afonso","researchInterest":""},{"lastName":"Majeti","clinicalFocus":[{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Hematology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Hematology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8250&type=small&showNoImage","displayName":"Ravindra Majeti","firstName":"Ravindra","href":"http://med.stanford.edu/profiles/cancer/researcher/Ravindra_Majeti","researchInterest":"Ravindra Majeti focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly acute myeloid leukemia (AML LSC). A major focus is the identification of cell surface molecules preferentially expressed on LSC and the development of therapeutic monoclonal antibodies targeting these proteins. Toward this goal, together with Irv Weissman, the lab is actively developing an anti-CD47 antibody for clinical trials in human AML."},{"lastName":"Owens","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - Primary Care Outcomes Research"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Academic Units - Freeman Spogli Institute for International Studies"},{"appointment":"Professor (By courtesy),Health Research & Policy"},{"appointment":"Professor (By courtesy),Management Science and Engineering - Management Sci Operations"}],"primaryAppointment":"Professor,Medicine - Primary Care Outcomes Research","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4649&type=small&showNoImage","displayName":"Douglas Owens","firstName":"Douglas","href":"http://med.stanford.edu/profiles/cancer/researcher/Douglas_Owens","researchInterest":"My research uses decision analysis, cost-effectiveness analysis, and meta-analysis to evaluate clinical and health policy problems."},{"lastName":"Benjamin","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Internal Medicine"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8612&type=small&showNoImage","displayName":"Jonathan Benjamin","firstName":"Jonathan","href":"http://med.stanford.edu/profiles/cancer/researcher/Jonathan_Benjamin","researchInterest":"My research interests adoptive transfer of defined subsets of lymphocytes for the treatment of hematologic malignancies. I have a specific interest in the treatment of Myelodysplastic Syndromes with non-myeloablative and reduced intensity transplant conditioning regimens."},{"lastName":"Garber","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Primary Care Outcomes Research"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Primary Care Outcomes Research","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4662&type=small&showNoImage","displayName":"Alan M. Garber","firstName":"Alan","href":"http://med.stanford.edu/profiles/cancer/researcher/Alan_Garber","researchInterest":"Topics in the health economics of aging; health, insurance; optimal screening intervals; cost-effectiveness of, coronary surgery in the elderly; health care financing and delivery, in the United States and Japan; coronary heart disease"},{"lastName":"Turakhia","clinicalFocus":[{"focus":"Cardiac Electrophysiology"},{"focus":"Arrhythmias, Cardiac"},{"focus":"Cardiology (Heart)"},{"focus":"Death, Sudden, Cardiac"},{"focus":"Catheter Ablation"},{"focus":"Atrial Fibrillation"},{"focus":"Implantable Defibrillators"},{"focus":"Tachycardia, Supraventricular"}],"appointments":[{"appointment":"Acting Assistant Professor,Medicine - Cardiovascular Medicine"}],"primaryAppointment":"Acting Assistant Professor,Medicine - Cardiovascular Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=11700&type=small&showNoImage","displayName":"Minang (Mintu) Turakhia","firstName":"Minang","href":"http://med.stanford.edu/profiles/cancer/researcher/Minang_Turakhia","researchInterest":"Dr. Turakhia's research program aims to improve the treatment of heart rhythm disorders by understanding system- and patient-level variation of arrhythmia treatment and their relationship to outcomes. He is principal investigator of the The Retrospective Evaluation and Assessment of Atrial Fibrillation study (TREAT-AF). With 400,000 patients, TREAT-AF will serve as the largest known research cohort of patients with Atrial Fibrillation."},{"lastName":"Wang","clinicalFocus":[{"focus":"Cardiac Electrophysiology"},{"focus":"Cardiology (Heart)"},{"focus":"Atrial Fibrillation"},{"focus":"Cardiac Arrhythmias"},{"focus":"Implantable Defibrillators"},{"focus":"Pacemakers"},{"focus":"Hypertrophic  Cardiomyopathy"},{"focus":"Cardiovascular Disease"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Cardiovascular Medicine"},{"appointment":"Professor - Med Center Line (By courtesy),Bioengineering"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Cardiovascular Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3939&type=small&showNoImage","displayName":"Paul  J. Wang, MD","firstName":"Paul","href":"http://med.stanford.edu/profiles/cancer/researcher/Paul_Wang","researchInterest":"Dr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments.  Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy.  Dr. Wang has active collaborations with Bioengineering, Mechanical Engineering, and Electrical Engineering Departments at Stanford."},{"lastName":"Gonzalgo","clinicalFocus":[{"focus":"Prostate Cancer - Robotic Prostatectomy"},{"focus":"Bladder Cancer - Robotic Cystectomy"},{"focus":"Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Urology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=13213&type=small&showNoImage","displayName":"Mark L. Gonzalgo, M.D., Ph.D.","firstName":"Mark","href":"http://med.stanford.edu/profiles/cancer/researcher/Mark_Gonzalgo","researchInterest":"My laboratory is focused on studying the role of DNA methylation in prostate and bladder cancer.  Certain genes and their downstream targets may be useful molecular markers for disease detection and prognostication. We are interested in utilizing methylation markers to detect abnormal changes in serum and urine.  Clinical Focus: Prostate Cancer - Robotic Prostatectomy; Bladder Cancer - Robotic Cystectomy; Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer."},{"lastName":"Volkmer","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute"}],"primaryAppointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=9789&type=small&showNoImage","displayName":"Jens-Peter Volkmer","firstName":"Jens-Peter","href":"http://med.stanford.edu/profiles/cancer/researcher/Jens-Peter_Volkmer","researchInterest":""},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4018&type=small&showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://med.stanford.edu/profiles/cancer/researcher/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Liedtke","clinicalFocus":[{"focus":"Multiple Myeloma"},{"focus":"Amyloidosis"},{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Assistant Professor - Med Center Line (By courtesy),Pathology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6984&type=small&showNoImage","displayName":"Michaela Liedtke","firstName":"Michaela","href":"http://med.stanford.edu/profiles/cancer/researcher/Michaela_Liedtke","researchInterest":"1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis\r\n\r\n2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)\r\n\r\n3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis\r\n\r\n4) Characterization of the molecular mechanism of MLL-induced acute leukemia"}]}